Sign in Sign up for free

Free Stock Screener

Load
Save
Create a watchlist Help
 
–
×
–
×
–
×
–
×
–
×
–
×
–
×
–
day ×
–
day ×
–
% ×
–
% ×
×
–
×
–
×
–
×
–
×
–
×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
day ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
×
–
% ×
–
×
–
×
–
% ×
–
×
–
×
–
×
–
×
–
×

TURN
180 Degree Capital Corp
Compare

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 31 Dec 2016 30 Sep 2016 30 Jun 2016 31 Mar 2016
Current assets
Cash $15.433919 $13.38482 $11.841767 $14.311324
Short term investments
Net receivables $0.079243 $0.593058 $0.170541
Inventory
Total current assets
Long term investments
Property, plant & equipment
Goodwill & intangible assets
Total noncurrent assets
Total investments $58.334309 $67.996587 $75.020758 $73.521729
Total assets $74.622068 $82.422674 $88.428366 $89.53337
Current liabilities
Accounts payable $0.877132 $0.632715 $0.671828 $0.550999
Deferred revenue
Short long term debt
Total current liabilities
Long term debt
Total noncurrent liabilities
Total debt $5 $5 $5
Total liabilities $2.366458 $7.099725 $7.144084 $7.028125
Stockholders' equity
Retained earnings -$139.653193 -$136.543529 -$130.521492 -$129.336447
Other stockholder equity $0.300237 $0.352482 $0.404728 $0.456974
Total stockholder equity $72.25561 $75.322949 $81.284282 $82.505245
(in millions USD) 2016 2015 2014
Current assets
Cash $15.433919 $17.92263 $20.748314
Short term investments
Net receivables $0.013032 $0.160877
Inventory
Total current assets
Long term investments
Property, plant & equipment
Goodwill & intangible assets
Total noncurrent assets
Total investments $58.334309 $77.152904 $89.76484
Total assets $74.622068 $96.461286 $112.094861
Current liabilities
Accounts payable $0.877132 $1.268355 $0.841915
Deferred revenue
Short long term debt
Total current liabilities
Long term debt
Total noncurrent liabilities
Total debt $5
Total liabilities $2.366458 $7.749615 $2.440434
Stockholders' equity
Retained earnings -$139.653193 -$123.286833 -$103.041003
Other stockholder equity $0.300237 $0.50922 $0.718203
Total stockholder equity $72.25561 $88.711671 $109.654427

Income statement

XSLX
XSLX
(in millions USD) 31 Dec 2016 30 Sep 2016 30 Jun 2016 31 Mar 2016
Revenue
Total revenue $0.463954 $0.566152 $0.460042 $0.302042
Cost of revenue
Gross profit $0.463954 $0.566152 $0.460042 $0.302042
Operating activities
Research & development
Selling, general & administrative $1.502807 $1.06029 $1.164242 $1.127692
Total operating expenses $1.652073 $1.213086 $1.300323 $1.255942
Operating income -$1.188119 -$0.646934 -$0.840281 -$0.9539
Income from continuing operations
EBIT -$2.851446 -$5.812156 -$0.978359 -$5.835758
Income tax expense -$0.002774 $0.00005 -$0.001339 $0.00583
Interest expense $0.260992 $0.209831 $0.208025 $0.208026
Net income
Net income -$3.109664 -$6.022037 -$1.185045 -$6.049614
Income (for common shares) -$3.109664 -$6.022037 -$1.185045 -$6.049614
(in millions USD) 2016 2015 2014
Revenue
Total revenue $1.79219 $0.916995 $0.5178
Cost of revenue
Gross profit $1.79219 $0.916995 $0.5178
Operating activities
Research & development
Selling, general & administrative $4.855031 $6.670468 $7.367759
Total operating expenses $5.421424 $7.308097 $8.041869
Operating income -$3.629234 -$6.391102 -$7.524069
Income from continuing operations
EBIT -$15.477719 -$19.472274 -$13.174866
Income tax expense $0.001767 $0.002148 $0.017896
Interest expense $0.886874 $0.771408 $0.377658
Net income
Net income -$16.36636 -$20.24583 -$13.57042
Income (for common shares) -$16.36636 -$20.24583 -$13.57042

Cash flows

XSLX
XSLX
(in millions USD) 31 Dec 2016 30 Sep 2016 30 Jun 2016 31 Mar 2016
Net income -$3.109664 -$6.022037 -$1.185045 -$6.049614
Operating activities
Depreciation $0.00017 -$0.122497 -$0.121992 -$0.108842
Business acquisitions & disposals
Stock-based compensation $0.111946 $0.11295 $0.038643 -$0.104566
Total cash flows from operations $7.066475 $1.544491 -$2.447242 -$3.611306
Investing activities
Capital expenditures -$0.001438
Investments
Total cash flows from investing -$0.001438
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings -$5
Total cash flows from financing -$5.017376 -$0.022315
Effect of exchange rate
Change in cash and equivalents $2.049099 $1.543053 -$2.469557 -$3.611306
(in millions USD) 2016 2015 2014
Net income -$16.36636 -$20.24583 -$13.57042
Operating activities
Depreciation -$0.353161 -$0.469224 -$0.109857
Business acquisitions & disposals
Stock-based compensation $0.158973 $0.798965 $0.857006
Total cash flows from operations $2.552418 -$6.52996 $12.361457
Investing activities
Capital expenditures -$0.001438 -$0.008816 -$0.02694
Investments
Total cash flows from investing -$0.001438 -$0.008816 -$0.02694
Financing activities
Dividends paid
Sale and purchase of stock -$1.199994
Net borrowings -$5 $5
Total cash flows from financing -$5.039691 $3.713092 -$0.124751
Effect of exchange rate
Change in cash and equivalents -$2.488711 -$2.825684 $12.209766

ACST
Acasti Pharma Inc
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 29 Sep 2022 29 Jun 2022 30 Mar 2022 30 Dec 2021
Current assets
Cash $34.926 $38.377 $30.339 $33.013
Short term investments $0.014 $0.016 $13.322 $13.312
Net receivables $0.859 $0.964 $0.548 $0.238
Inventory
Other current assets $0.352 $0.352 $0.602 $0.587
Total current assets $37.505 $41.248 $45.531 $48.997
Long term investments
Property, plant & equipment $0.632 $0.909 $0.315 $0.022
Goodwill $12.964 $12.964 $12.964
Intangible assets $69.81 $69.81 $69.81 $65.208
Other assets
Total assets $120.911 $124.931 $128.62 $114.227
Current liabilities
Accounts payable $3.735 $3.062 $1.678 $2.843
Short long term debt
Other current liabilities $0.032
Total current liabilities $3.805 $3.707 $3.26 $2.897
Long term debt
Other liabilities $16.492 $16.647 $16.899 $0.268
Minority interest
Total liabilities $20.747 $20.528 $20.35 $3.165
Stockholders' equity
Common stock $258.294 $258.185 $257.99 $257.99
Retained earnings -$165.29 -$160.361 -$155.837 -$151.933
Treasury stock -$6.04 -$6.039 -$6.037 -$6.533
Capital surplus $13.2 $12.618 $12.154 $11.538
Total stockholder equity $100.164 $104.403 $108.27 $111.062
Net tangible assets $17.39 $21.629 $25.496 $45.854
(in millions USD) 2022 2021 2020
Current assets
Cash $30.339 $50.942 $14.24
Short term investments $13.322 $9.789
Net receivables $0.548 $0.53 $0.546
Inventory
Other current assets $0.602 $0.768 $2.699
Total current assets $45.531 $62.372 $18.462
Long term investments
Property, plant & equipment $0.315 $0.086 $0.147
Goodwill $12.964
Intangible assets $69.81 $4.244
Other assets
Total assets $128.62 $62.458 $22.853
Current liabilities
Accounts payable $1.678 $0.115 $1.713
Short long term debt
Other current liabilities
Total current liabilities $3.26 $1.579 $7.395
Long term debt
Other liabilities $16.899 $5.219 $2.393
Minority interest
Total liabilities $20.35 $6.798 $9.859
Stockholders' equity
Common stock $257.99 $197.194 $137.424
Retained earnings -$155.837 -$146.018 -$126.34
Treasury stock -$6.037 -$6.333 -$7.887
Capital surplus $12.154 $10.817 $9.797
Total stockholder equity $108.27 $55.66 $12.994
Net tangible assets $25.496 $55.66 $8.75

Income statement

XSLX
XSLX
(in millions USD) 29 Sep 2022 29 Jun 2022 30 Mar 2022 30 Dec 2021
Revenue
Total revenue
Cost of revenue
Gross profit
Operating activities
Research & development $3.292 $2.59 $2.326 $2.179
Selling, general & administrative $1.816 $2.14 $2.077 $2.046
Total operating expenses $5.108 $4.73 $4.403 $4.225
Operating income -$5.108 -$4.73 -$4.403 -$4.225
Income from continuing operations
Net other income $0.024 -$0.036 -$0.149 $0.447
EBIT -$5.108 -$4.73 -$4.403 -$4.225
Income before tax -$5.084 -$4.766 -$4.552 -$3.778
Income tax expense -$0.155 -$0.242 -$0.648
Minority interest
Net income
Net income -$4.929 -$4.524 -$3.904 -$3.778
Income (for common shares) -$4.929 -$4.524 -$3.904 -$3.778
(in millions USD) 2022 2021 2020
Revenue
Total revenue $0.196
Cost of revenue $0.076
Gross profit $0.12
Operating activities
Research & development $5.559 $4.173 $15.974
Selling, general & administrative $6.581 $6.663 $8.464
Total operating expenses $12.14 $10.912 $24.438
Operating income -$12.14 -$10.716 -$24.438
Income from continuing operations
Net other income $1.673 -$8.962 -$1.075
EBIT -$12.14 -$10.716 -$24.438
Income before tax -$10.467 -$19.678 -$25.513
Income tax expense -$0.648
Minority interest
Net income
Net income -$9.819 -$19.678 -$25.513
Income (for common shares) -$9.819 -$19.678 -$25.513

Cash flows

XSLX
XSLX
(in millions USD) 29 Sep 2022 29 Jun 2022 30 Mar 2022 30 Dec 2021
Net income -$4.929 -$4.524 -$3.904 -$3.778
Operating activities
Depreciation -$0.061 $0.167 $0.167 $0.167
Change in accounts receivable $0.075 -$0.434 -$0.31 $0.579
Changes in inventory
Total cash flows from operations -$3.439 -$5.426 -$3.145 -$4.584
Investing activities
Capital expenditures -$0.002 -$0.007 -$0.007 -$0.007
Investments -$0.094 $13.265 $0.011 $0.557
Other cash flows from investing
Total cash flows from investing -$0.096 $13.258 $0.011 $0.557
Financing activities
Dividends paid
Net borrowings
Other cash flows from financing
Total cash flows from financing $0.109 $0.195 $0.195 $0.195
Effect of exchange rate -$0.025 $0.011 $0.46 $0.111
Change in cash and equivalents -$3.451 $8.038 -$2.674 -$3.916
(in millions USD) 2022 2021 2020
Net income -$9.819 -$19.678 -$25.513
Operating activities
Depreciation $0.924 $2.32
Change in accounts receivable -$0.018 $0.058 $0.581
Changes in inventory
Total cash flows from operations -$17.234 -$14.319 -$22.951
Investing activities
Capital expenditures -$0.069 -$0.319
Investments -$3.522 -$9.789 $8.457
Other cash flows from investing
Total cash flows from investing -$3.522 -$9.858 $8.138
Financing activities
Dividends paid
Net borrowings -$1.556
Other cash flows from financing -$0.143 $0.007
Total cash flows from financing $59.49 $13.183
Effect of exchange rate $0.153 $1.389 -$1.001
Change in cash and equivalents -$20.603 $36.702 -$2.631

AXDX
Accelerate Diagnostics Inc
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Current assets
Cash $8.588 $14.606 $12.138 $20.162
Short term investments $1.158 $1.145 $1.081 $0.989
Net receivables $2.289 $2.217 $2.622 $2.666
Inventory $3.223 $3.249 $3.31 $3.553
Total current assets $17.17 $24.133 $24.466 $32.443
Long term investments
Property, plant & equipment $4.815 $5.379 $5.084 $5.768
Goodwill & intangible assets
Total noncurrent assets $5.697 $6.589 $6.9 $6.881
Total investments $1.158 $1.145 $1.081 $0.989
Total assets $22.867 $30.722 $31.366 $39.324
Current liabilities
Accounts payable $3.759 $5.108 $4.796 $4.812
Deferred revenue $1.925 $2.382 $2.667 $1.686
Short long term debt $1.208 $2.351 $2.286 $2.157
Total current liabilities $13.413 $16.131 $12.034 $37.786
Long term debt $41.202 $38.064 $36.934 $34.413
Total noncurrent liabilities $44.341 $40.371 $39.22 $36.571
Total debt $42.41 $40.415 $39.22 $36.57
Total liabilities $57.754 $56.502 $51.254 $74.357
Stockholders' equity
Retained earnings -$694.675 -$683.087 -$668.857 -$655.859
Other stockholder equity -$0.449 -$0.618 -$0.612 -$0.36
Total stockholder equity -$34.887 -$25.78 -$19.888 -$35.033
(in millions USD) 2023 2022 2021
Current assets
Cash $12.138 $34.905 $39.898
Short term investments $1.081 $10.656 $23.72
Net receivables $2.622 $2.416 $2.32
Inventory $3.31 $5.194 $5.067
Total current assets $24.466 $56.014 $73.331
Long term investments
Property, plant & equipment $5.084 $7.759 $7.899
Goodwill & intangible assets
Total noncurrent assets $6.9 $9.001 $9.716
Total investments $1.081 $10.656 $23.72
Total assets $31.366 $65.015 $83.047
Current liabilities
Accounts payable $4.796 $4.501 $1.983
Deferred revenue $2.667 $0.547 $0.451
Short long term debt $2.286 $58.355 $0.749
Total current liabilities $12.034 $66.557 $6.945
Long term debt $36.934 $19.185 $110.365
Total noncurrent liabilities $39.22 $20.722 $111.173
Total debt $39.22 $77.54 $111.114
Total liabilities $51.254 $87.279 $118.118
Stockholders' equity
Retained earnings -$668.857 -$607.239 -$570.668
Other stockholder equity -$0.612 -$0.4 -$0.06
Total stockholder equity -$19.888 -$22.264 -$35.071

Income statement

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Revenue
Total revenue $2.986 $2.921 $3.027 $3.299
Cost of revenue $2.31 $2.198 $2.394 $3.192
Gross profit $0.676 $0.723 $0.633 $0.107
Operating activities
Research & development $3.903 $5.173 $5.57 $6.996
Selling, general & administrative $5.379 $5.706 $5.793 $7.761
Total operating expenses $9.282 $10.879 $11.363 $14.757
Operating income -$8.606 -$10.156 -$10.73 -$14.65
Income from continuing operations
EBIT -$8.999 -$11.78 -$10.306 $3.246
Income tax expense $0.564 $0.131
Interest expense $2.589 $2.45 $2.128 $2.205
Net income
Net income -$11.588 -$14.23 -$12.998 $0.91
Income (for common shares) -$11.588 -$14.23 -$12.998 $0.91
(in millions USD) 2023 2022 2021
Revenue
Total revenue $12.059 $12.752 $11.782
Cost of revenue $9.509 $9.449 $12.163
Gross profit $2.55 $3.303 -$0.381
Operating activities
Research & development $25.353 $26.915 $21.943
Selling, general & administrative $31.225 $39.193 $49.236
Total operating expenses $56.578 $66.108 $71.179
Operating income -$54.028 -$62.805 -$71.56
Income from continuing operations
EBIT -$53.025 -$58.799 -$62.112
Income tax expense $0.85 -$0.077 $0.045
Interest expense $7.743 $3.771 $15.545
Net income
Net income -$61.618 -$62.493 -$77.702
Income (for common shares) -$61.618 -$62.493 -$77.702

Cash flows

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Net income -$11.588 -$14.23 -$12.998 $0.91
Operating activities
Depreciation $0.877 $0.858 $0.82 $0.817
Business acquisitions & disposals
Stock-based compensation $0.966 $1.297 $1.364 $1.815
Total cash flows from operations -$7.583 -$8.452 -$7.755 -$8.253
Investing activities
Capital expenditures -$0.002 -$0.513 -$0.11 -$0.758
Investments $0.404
Total cash flows from investing -$0.002 -$0.513 -$0.11 -$0.354
Financing activities
Dividends paid
Sale and purchase of stock $10.232
Net borrowings -$1.184 -$0.079 -$3.624 -$0.817
Total cash flows from financing $1.396 $11.439 $0.107 -$0.817
Effect of exchange rate $0.171 -$0.006 -$0.266 $0.304
Change in cash and equivalents -$6.018 $2.468 -$8.024 -$9.12
(in millions USD) 2023 2022 2021
Net income -$61.618 -$62.493 -$77.702
Operating activities
Depreciation $3.254 $3 $2.518
Business acquisitions & disposals
Stock-based compensation $5.387 $10.625 $22.047
Total cash flows from operations -$40.196 -$48.728 -$47.323
Investing activities
Capital expenditures -$1.035 -$0.554 -$0.603
Investments $9.695 $12.971 $8.907
Total cash flows from investing $8.66 $12.417 $8.304
Financing activities
Dividends paid
Sale and purchase of stock $4 $33.103 $44.826
Net borrowings $5.019 -$1.281 -$0.36
Total cash flows from financing $9.019 $31.63 $43.226
Effect of exchange rate -$0.25 -$0.312 -$0.09
Change in cash and equivalents -$22.767 -$4.993 $4.117

ARAY
Accuray Inc
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 31 Mar 2024 31 Dec 2023 30 Sep 2023 30 Jun 2023
Current assets
Cash $62.154 $74.492 $78.691 $91.202
Short term investments
Net receivables $73.154 $77.397 $77.37 $74.777
Inventory $159.566 $155.228 $149.977 $145.15
Total current assets $313.91 $331.17 $334.147 $338.033
Long term investments $13.586 $14.536 $13.121 $15.128
Property, plant & equipment $54.514 $49.013 $49.341 $46.779
Goodwill & intangible assets $57.752 $57.887 $57.819 $57.891
Total noncurrent assets $148.617 $145.18 $142.683 $141.181
Total investments $13.586 $14.536 $13.121 $15.128
Total assets $462.527 $476.35 $476.83 $479.214
Current liabilities
Accounts payable $44.43 $39.18 $34.877 $33.739
Deferred revenue $97.358 $102.215 $98.703 $99.264
Short long term debt $12.527 $12.445 $12.306 $9.872
Total current liabilities $198.39 $209.306 $201.449 $198.637
Long term debt $194.463 $189.778 $192.598 $195.164
Total noncurrent liabilities $223.056 $219.391 $224.437 $226.918
Total debt $206.99 $202.223 $204.904 $205.036
Total liabilities $421.446 $428.697 $425.886 $425.555
Stockholders' equity
Retained earnings -$521.068 -$514.726 -$505.105 -$502.136
Other stockholder equity -$1.908 $1.057 -$1.716 $0.422
Total stockholder equity $41.081 $47.653 $50.944 $53.659
(in millions USD) 2023 2022 2021
Current assets
Cash $91.202 $90.154 $118.201
Short term investments
Net receivables $74.777 $94.442 $85.36
Inventory $145.15 $142.254 $125.929
Total current assets $338.033 $350.89 $352.773
Long term investments $15.128 $13.879 $15.935
Property, plant & equipment $46.779 $29.483 $34.854
Goodwill & intangible assets $57.891 $58.09 $58.395
Total noncurrent assets $141.181 $121.959 $127.325
Total investments $15.128 $13.879 $15.935
Total assets $479.214 $472.849 $480.098
Current liabilities
Accounts payable $33.739 $31.337 $19.467
Deferred revenue $99.264 $100.069 $105.345
Short long term debt $9.872 $17.13 $11.959
Total current liabilities $198.637 $208.858 $192.359
Long term debt $195.164 $182.36 $187.448
Total noncurrent liabilities $226.918 $210.802 $218.899
Total debt $205.036 $199.49 $199.407
Total liabilities $425.555 $419.66 $411.258
Stockholders' equity
Retained earnings -$502.136 -$492.522 -$488.024
Other stockholder equity $0.422 $2.406 $2.093
Total stockholder equity $53.659 $53.189 $68.84

Income statement

XSLX
XSLX
(in millions USD) 31 Mar 2024 31 Dec 2023 30 Sep 2023 30 Jun 2023
Revenue
Total revenue $101.132 $107.238 $103.892 $118.292
Cost of revenue $72.058 $71.336 $64.399 $80.614
Gross profit $29.074 $35.902 $39.493 $37.678
Operating activities
Research & development $10.909 $15.281 $14.013 $14.187
Selling, general & administrative $22.727 $24.585 $23.267 $23.948
Total operating expenses $33.636 $39.866 $37.28 $38.135
Operating income -$4.562 -$3.964 $2.213 -$0.457
Income from continuing operations
EBIT -$5.898 -$8.743 -$1.037 -$1.976
Income tax expense $0.444 $0.878 $1.932 $0.58
Interest expense
Net income
Net income -$6.342 -$9.621 -$2.969 -$2.556
Income (for common shares) -$6.342 -$9.621 -$2.969 -$2.556
(in millions USD) 2023 2022 2021
Revenue
Total revenue $447.605 $429.909 $396.289
Cost of revenue $293.645 $269.954 $236.782
Gross profit $153.96 $159.955 $159.507
Operating activities
Research & development $57.129 $57.752 $52.729
Selling, general & administrative $94.449 $94.055 $84.543
Total operating expenses $151.578 $151.807 $137.272
Operating income $2.382 $8.148 $22.235
Income from continuing operations
EBIT -$6.788 -$2.002 -$4.559
Income tax expense $2.492 $3.345 $1.752
Interest expense
Net income
Net income -$9.28 -$5.347 -$6.311
Income (for common shares) -$9.28 -$5.347 -$6.311

Cash flows

XSLX
XSLX
(in millions USD) 31 Mar 2024 31 Dec 2023 30 Sep 2023 30 Jun 2023
Net income -$6.342 -$9.621 -$2.969 -$2.556
Operating activities
Depreciation $1.601 $1.546 $1.251 $1.097
Business acquisitions & disposals $0.059
Stock-based compensation $2.735 $2.314 $2.392 $2.452
Total cash flows from operations -$8.102 -$5.093 -$8.591 $8.881
Investing activities
Capital expenditures -$0.795 -$1.249 -$1.092 -$8.035
Investments
Total cash flows from investing -$0.795 -$1.249 -$1.092 -$7.976
Financing activities
Dividends paid
Sale and purchase of stock $1.36 $1.061
Net borrowings -$1.5 -$1.5 -$1.5 -$1.5
Total cash flows from financing -$1.5 -$0.257 -$1.5 -$0.522
Effect of exchange rate -$1.941 $2.4 -$1.328 -$0.031
Change in cash and equivalents -$12.338 -$4.199 -$12.511 $0.352
(in millions USD) 2023 2022 2021
Net income -$9.28 -$5.347 -$6.311
Operating activities
Depreciation $4.527 $5.513 $6.389
Business acquisitions & disposals -$0.079
Stock-based compensation $10.053 $10.6 $9.332
Total cash flows from operations $15.539 -$2.4 $38.512
Investing activities
Capital expenditures -$12.614 -$4.717 -$2.32
Investments
Total cash flows from investing -$12.681 -$4.717 -$2.399
Financing activities
Dividends paid
Sale and purchase of stock $2.2 $3.889 -$11.05
Net borrowings -$4.113 -$19 -$17.412
Total cash flows from financing -$2.112 -$15.369 -$28.805
Effect of exchange rate $0.302 -$5.561 $0.982
Change in cash and equivalents $1.048 -$28.047 $8.29

ACRX
Acelrx Pharmaceuticals Inc
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Dec 2022
Current assets
Cash $13.389 $7.41 $13.353 $20.275
Short term investments $0.495
Net receivables $0.309
Inventory $1.178
Total current assets $14.422 $8.836 $17.354 $24.566
Long term investments
Property, plant & equipment $0.049 $13.856
Goodwill & intangible assets
Total noncurrent assets $8.839 $8.889 $8.938 $22.921
Total investments $0.495
Total assets $23.261 $17.725 $26.292 $47.487
Current liabilities
Accounts payable $1.026 $1.212 $1.398 $2.04
Deferred revenue $1.036
Short long term debt $3.369 $7.464
Total current liabilities $3.574 $4.22 $9.463 $13.77
Long term debt $2.959
Total noncurrent liabilities $1.38 $3.086 $2.587 $11.903
Total debt $3.369 $10.423
Total liabilities $4.954 $7.306 $12.05 $25.673
Stockholders' equity
Retained earnings -$439.709 -$438.352 -$433.981 -$425.829
Other stockholder equity
Total stockholder equity $18.307 $10.419 $14.242 $21.814
(in millions USD) 2022 2021 2020
Current assets
Cash $20.275 $12.663 $27.274
Short term investments $0.495 $38.967 $15.612
Net receivables $0.309 $0.16 $0.635
Inventory $1.178 $1.111 $1.626
Total current assets $24.566 $55.489 $46.83
Long term investments
Property, plant & equipment $13.856 $20.23 $18.809
Goodwill & intangible assets
Total noncurrent assets $22.921 $22.404 $19.465
Total investments $0.495 $38.967 $15.612
Total assets $47.487 $77.893 $66.295
Current liabilities
Accounts payable $2.04 $2.121 $2.737
Deferred revenue $1.036 $1.151 $0.049
Short long term debt $7.464 $9.864 $9.853
Total current liabilities $13.77 $18.509 $17.635
Long term debt $2.959 $8.757 $15.746
Total noncurrent liabilities $11.903 $95.277 $104.41
Total debt $10.423 $18.621 $25.599
Total liabilities $25.673 $113.786 $122.045
Stockholders' equity
Retained earnings -$425.829 -$473.584 -$438.485
Other stockholder equity
Total stockholder equity $21.814 -$35.893 -$55.75

Income statement

XSLX
XSLX
(in millions USD) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Dec 2022
Revenue
Total revenue $0.117 $0.253 $0.252
Cost of revenue $0.362
Gross profit $0.117 $0.253 -$0.11
Operating activities
Research & development $1.178 $1.552 $1.047 $1.026
Selling, general & administrative $2.248 $2.67 $4.281 $6.25
Total operating expenses $3.426 $4.222 $5.328 $7.323
Operating income -$3.309 -$3.969 -$5.328 -$7.433
Income from continuing operations
EBIT -$1.355 -$3.912 -$8.033 -$7.296
Income tax expense $0.002 $0.003 -$0.001
Interest expense $0.456 $0.119 $0.189
Net income
Net income -$1.357 -$4.371 -$8.152 -$7.484
Income (for common shares) -$1.357 -$4.371 -$8.152 -$12.595
(in millions USD) 2022 2021 2020
Revenue
Total revenue $1.771 $2.818 $5.416
Cost of revenue $2.591 $3.753 $6.032
Gross profit -$0.82 -$0.935 -$0.616
Operating activities
Research & development $5.193 $4.095 $4.017
Selling, general & administrative $25.672 $30.935 $36.33
Total operating expenses $35.813 $35.03 $40.347
Operating income -$36.633 -$35.965 -$40.963
Income from continuing operations
EBIT $48.921 -$32.803 -$37.07
Income tax expense $0.013 $0.005 $0.004
Interest expense $1.153 $2.291 $3.305
Net income
Net income $47.755 -$35.099 -$40.379
Income (for common shares) $42.329 -$35.099 -$40.379

Cash flows

XSLX
XSLX
(in millions USD) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Dec 2022
Net income -$1.357 -$4.371 -$8.152 -$7.484
Operating activities
Depreciation $0.049 $0.262 $0.342
Business acquisitions & disposals $2.723
Stock-based compensation $0.378 $0.471 $0.569 $0.652
Total cash flows from operations -$2.96 -$5.333 -$5.25 -$5.413
Investing activities
Capital expenditures -$0.1 -$0.048
Investments $0.5 $2.708
Total cash flows from investing $2.723 $0.4 $2.66
Financing activities
Dividends paid
Sale and purchase of stock $8.939 $0.033 $7.794
Net borrowings -$3.333 -$2.083 -$2.183
Total cash flows from financing $8.939 -$3.333 -$2.072 $5.296
Effect of exchange rate
Change in cash and equivalents $5.979 -$5.943 -$6.922 $2.543
(in millions USD) 2022 2021 2020
Net income $47.755 -$35.099 -$40.379
Operating activities
Depreciation $1.647 $1.973 $1.853
Business acquisitions & disposals -$1.687 -$0.821
Stock-based compensation $2.889 $4.609 $4.424
Total cash flows from operations -$28.331 -$30.002 -$38.505
Investing activities
Capital expenditures -$0.364 -$1.827 -$1.855
Investments $38.501 -$23.475 $35.994
Total cash flows from investing $36.45 -$26.123 $34.139
Financing activities
Dividends paid
Sale and purchase of stock $8.06 $50.596 $21.709
Net borrowings -$8.433 -$8.833 -$4.667
Total cash flows from financing -$0.507 $41.514 $16.956
Effect of exchange rate
Change in cash and equivalents $7.612 -$14.611 $12.59